TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD

Journal of Hepatology

Volumn 64, Issue 4, 2016, Pages 979-981

  Musso, Giovanni ^a   Cassader, Maurizio ^b   Paschetta, Elena ^a   Gambino, Roberto ^b  

^a GRADENIGO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; MEMBRANE PROTEIN; TRIACYLGLYCEROL;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; FAT CONTENT; FAT TOLERANCE TEST; FATTY LIVER; GENE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; LETTER; LIPIDOMICS; LIPOTOXICITY; LIVER CELL; NONALCOHOLIC FATTY LIVER; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 GENE; BLOOD; FEMALE; GENETIC VARIATION; GENETICS; MALE; METABOLISM;

FEMALE; GENETIC VARIATION; HUMANS; MALE; MEMBRANE PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES;

EID: 84961922814     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.11.036     Document Type: Letter

References (10)

1. Y. Zhou, G. Llauradó, M. Orešič, T. Hyötyläinen, M. Orho-Melander, and H. Yki-Järvinen Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2 J Hepatol 62 2015 657 663
2. Y.L. Liu, H.L. Reeves, A.D. Burt, D. Tiniakos, S. McPherson, J.B. Leathart, and et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309
3. P. Dongiovanni, S. Petta, C. Maglio, A.L. Fracanzani, R. Pipitone, E. Mozzi, and et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease Hepatology 61 2015 506 514
4. J. Chen, Y. Zhu, Q. Zheng, and J. Jiang Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis Hepatol Res 44 2014 854 862
5. G. Musso, M. Cassader, S. Bo, F. De Michieli, and R. Gambino Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism Diabetes 62 2013 1109 1120
6. G. Musso, M. Cassader, F. De Michieli, F. Rosina, F. Orlandi, and R. Gambino Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism Hepatology 56 2012 933 942
7. G. Musso, R. Gambino, and M. Cassader Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis Prog Lipid Res 52 2013 175 191
8. H. Jo, S.S. Choe, K.C. Shin, and H. Jang Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic VLDLR Hepatology 57 2013 1366 1377
9. V.T. Männistö, M. Simonen, P. Soininen, and M. Tiainien Lipoprotein subclass metabolism in nonalcoholic steatohepatitis J Lipid Res 55 2014 2676 2684
10. G. Musso, M. Cassader, and R. Gambino Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies Nat Rev Drug Discov 2016 10.1038/nrd.2015.3 [Epub ahead of print]